Tag: Mindray

Reading Time: 2 minutes HMIN looked cheap these days, should we jump in and buy it? I have both MR and HMIN, and as a matter of fact, I bought some more HMIN after its disappointing earning report. My mistake. You may think because HMIN has been to $49, and now it’s trading $29.50, isn’t a big discount? Yes or

stlplace
May 30, 2007

Reading Time: 2 minutes This is the report. From the Conference call, it appears they made a mistake on the announcement, I believe there was a typo on the first bullet (should be 40% rather than 24.7% YoY if exclude the large bid in 2006) My comments on the results:  

stlplace
May 14, 2007

Reading Time: < 1 minute Well, Xinhua Finance Media Limited XFML IPO nearly broke my heart, kind as I expected. The good thing is WR Hambrecht only allocated me 100 shares, out of 200 shares I indicated to buy. On a positive note, Mindray reported a good quarter and a good year. Here is the results. Going forward they expect

stlplace
March 12, 2007

Reading Time: < 1 minute Mindray, the leading medical device maker in Shenzhen, is hiring. Here is the link in Chinese. Most are R&D positions. And some campus recruiting events. Interestingly, I noticed they are looking for Spanish, Portuguese, German and Russian speaking sales person, as shown in this ad. From this and previous company’s SEC filings we can see the company still

stlplace
February 27, 2007

Reading Time: < 1 minute It appears that Mindray started new offering today. I read its SEC filings here. The insiders will sell 9,827,220 shares and the underwriter will have option to buy additional 1,474,083 shares from selling share holders. That alone won’t have dilution effect. Separately, the company filed S1 form for stock options registration. That will dilute the

stlplace
January 31, 2007

Reading Time: 2 minutes (Update 12-14-2023) Came across this issue again when doing some research on the Hashicorp stock ($HCP). CEO David McJannet Confounder Armon Dadgar  I assume cofounder Mitchell Hashimoto has a shell company and didn’t use his own name for the shares he traded. I didn’t dig into it: it’s not something that I feel it’s productive

stlplace
January 22, 2007

Reading Time: < 1 minute I summerized its year 2005 and 2006 (low end) number here. I noted that the revenue year over year growth slowed a bit (consider first 9 months growth about 41%). This can be attribute to the continuing “anti-corruption” campaign in China hospitals.                   2005               2006              YoY Rev (CNY)  1,078,573,000 1,470,000,000 36.29%      Income         205,089,000    360,000,000 75.53%      Earning (CNY)           2.40                3.73 55.42%

stlplace
January 17, 2007

Reading Time: 2 minutes Home Inns (HMIN) and Mindray (MR) both reported their Q3 earning last week. I listened to both the conference calls. HMIN obviously did better with revenue growth: RMB 160.4 m, 106.3% year over year growth. Mindray’s revenue growth was 21.6% because of the anti-corruption campaign in Chinese hospitals. I think that growth factor determined the stock

stlplace
November 18, 2006

Reading Time: 2 minutes OK, enough about the Home Inns (HMIN) and New Oriental (EDU), both of which are well known consumer brands based in Shanghai and Beijing respectively. On Sept 26, a not so well known medical device company based in Shenzhen (by Hongkong), did IPO on NYSE and it was well received by the investors. The company is Mindray Medical International, ticker symbol

stlplace
October 31, 2006
Follow Us
Meta
Google Ads
Archives
Pages
Recent Comments
Recent Posts
Tags
Categories